MORRISTOWN, N.J., July27, 2017(GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) ("Pernix" or the "Company"), a specialty pharmaceutical company, today announced financial results for the three and six months ended June 30, 2017. Second Quarter 2017 Financial Highlights:Second q...Read More
TORONTO, ONTARIO--(Marketwired - July 25, 2017) - Platinex Inc. (CSE:PTX)(CSE:PTX.CN)(CNSX:PTX) ("Platinex" or the "Company") has engaged FMI Capital Advisory Inc. ("FMI") as financial advisor to assist in its efforts to grow, finance, secure projects, and in connection with a tr...Read More
TORONTO, ONTARIO--(Marketwired - July 21, 2017) - Platinex Inc. (CSE:PTX)(CSE:PTX.CN)(CNSX:PTX) (the "Company" or "Platinex") announces that the forty five day period set out in a Letter of Intent with Cannabee Products, Inc announced on June 7, 2017 has expired without concludin...Read More
MORRISTOWN, N.J., July20, 2017(GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) ("Pernix" or the "Company"), a specialty pharmaceutical company, today announced certain preliminary unaudited financial results for the second quarter ended June 30, 2017. Second Quarter 2017 Preli...Read More
MORRISTOWN, N.J., July20, 2017(GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) ("Pernix" or the "Company"), a specialty pharmaceutical company, today commenced a series of refinancing transactions intended to improve liquidity, extend debt maturities and enable the Company to...Read More
TORONTO, ONTARIO--(Marketwired - June 29, 2017) - Platinex Inc. (CSE:PTX)(CSE:PTX.CN)(CNSX:PTX) ("Platinex" or the "Company") announces the launch of their brand new community resource website, on Saturday, July 1st, 2017. The URL is www.cannabismall.org. The intention of the s...Read More
MORRISTOWN, N.J., June28, 2017(GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) ("Pernix" or the "Company"), announced today that it has been added to the Russell Microcap (R) index following the annual reconstitution, which took effect after the US market closed on Friday, Jun...Read More
MORRISTOWN, N.J., May15, 2017(GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) ("Pernix" or the "Company"), a specialty pharmaceutical company, today announced financial results for the three months ended March 31, 2017. First Quarter 2017 Financial Highlights:First quarter 2017...Read More
SEATTLE, WA--(Marketwired - May 25, 2017) -CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces publication of an article discussing Platinex Inc.'s (CSE: PTX) experienced team behind the launch of CannabisMall.Shop and CannabisMal...Read More
TORONTO, ONTARIO--(Marketwired - June 7, 2017) - Platinex Inc. (CSE:PTX)(CSE:PTX.CN)(CNSX:PTX) ("Platinex" or the "Company") has signed a forty five day Letter of Intent with Cannabee Products, Inc. ("Cannabee") to acquire Cannabee in a share purchase agreement. Founded in 200...Read More
TORONTO, ONTARIO--(Marketwired - Jun 19, 2017) - Platinex Inc. (CSE:PTX)(CSE:PTX.CN)(CNSX:PTX) ("Platinex" or the "Company") announces the target date of July 1st, 2017 to launch its Cannabismall.org community resource website. The Company's objective is to become a voice in the communi...Read More
TORONTO, ONTARIO--(Marketwired - June 21, 2017) - Platinex Inc. (CSE:PTX)(CSE:PTX.CN)(CNSX:PTX) (the "Company") has agreed to purchase 127 claim units totaling 2,032 hectares (5,080 acres) in the Shining Tree area of Ontario. The vendor will receive 436,190 shares of Platinex...Read More